• Products
  • Resources
  • Our Team
  • News
  • Contact Sales
  • 

Ogibiotec Announces Strategic Investment Led by Existing investors Merleview, Scottish Enterprise, TRICAPITAL Angels Limited and Apollo Informal Investments

by Matthew Scheier | Jul 22, 2025 | Growth

We are delighted to announce that Ogibiotec has successfully secured a significant investment round, led by our existing investors Merleview Capital, with continued backing from Scottish Enterprise, TRICAPITAL Angels Limited and Apollo Informal Investments.  ...

End User License

by Matthew Scheier | Jun 3, 2025 | License Agreement

Ogibiotec End User License Agreement

Subscription License

by Matthew Scheier | Jun 3, 2025 | License Agreement

Ogibiotec Subscription License Agreement
Major Milestone for ogibiotec: The OGI3 Bioreactor System is Shipping

Major Milestone for ogibiotec: The OGI3 Bioreactor System is Shipping

by Matthew Scheier | Dec 16, 2024 | Blog, Tech

Ogibiotec is thrilled to announce the OGI3 Bioreactor System is officially shipping to companies and researchers worldwide! In the quest for better, more scalable data in microbial growth and analytics, the OGI3 delivers an automated, modular system that makes...

OGI3 BioReactor System Version 4.4.0

by Matthew Scheier | Nov 8, 2024 | Latest Software

OGI3 BioReactor System Version 4.4.0 – Download  
« Older Entries

Recent Posts

  • Ogibiotec Announces Strategic Investment Led by Existing investors Merleview, Scottish Enterprise, TRICAPITAL Angels Limited and Apollo Informal Investments
  • Terms and Conditions
  • End User License
  • Subscription License
  • Quality Lead

info@ogibiotec.com

Unit 3
Glencorse Building
Pentland Science Park
Bush Loan
EH26 0PZ

  • Products
  • Resources
  • Our Team
  • News
  • Contact Sales
  • Login

Privacy Policy

  • Follow
© 2025 OgiBio. All Rights Reserved. Site by Yourweb.